Products for topical application comprising lysophospholipids and fatty acids

a technology of lysophospholipids and fatty acids, applied in the field of topical application products, can solve the problems of inconvenient use, large distress, and conventional therapies for hyperhidrosis, and achieve the effect of effective lowering the smell and increasing the effect of the

Inactive Publication Date: 2007-02-15
CESARE MONTECUCCO
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0017] Such a product is useful for therapeutically treating hyperhidrosis conditions, in particular hyperhidrosis of palms, soles of the feet and axillae, for the cosmetic treatment of facial wrinkles, and in all those conditions which will benefit from the relaxation of superficial human muscles in general. The present application is also valid to effectively lower the smelling associated to excessive sweating and it can be included in anti axillary smelling products to increase their efficacy.

Problems solved by technology

This disorder is a cause of great distress for patients suffering therefrom.
Conventional therapies for hyperhidrosis (use of topical aluminum chloride salts, glutaraldehyde mixtures, anticholinergic drugs) are not free of inconveniences and are often unsuccessful.
However, it is questionable that proteins as big as botulinum toxin might be absorbed to a significant extent and in any case formulations containing DMSO are not desirable because DMSO can irritate the skin.
However, this treatment is not free of inconveniences.
For example, botulinum toxin may diffuse from the injected muscle to adjacent muscles and the resulting muscle paralysis may cause double vision or ptosis.
In addition, the treatment causes frequently a decrease of facial expression.
Moreover, it has been observed that some patients, after an initial benefit from this treatment, later became insensitive to it.
Another significant drawback for botulinum toxin treatment lies in that the toxin has to be delivered by subcutaneous injections, performed by a skilled medical practitioner.
This method is, however, apparently not suitable for being autonomously carried out by a subject in need for cosmetic treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0040]

Ointment1-Myristoyl-sn-glycero-3-phosphocholine7.7%Oleic acid5.0%Vaseline58.3% Cetostearyl alcohol 23%Cetomacrogol  6%

[0041] This ointment is prepared by heating the components together until they melt and agitating until cooling has occurred.

example 2

[0042]

W / O Cream1-Myristoyl-sn-glycero-3-phosphocholine 8%Oleic acid5.5% Vaseline37%Almond oil 3%Cetostearyl alcohol17%Cetomacrogol (1000)4.5% Purified water25%

[0043] The cream is prepared by melting the solid components in the vaseline and adding freshly boiled water at the same temperature, agitating slowly until cooling has occurred and reintegrating any evaporated water.

example 3

[0044]

Hydrophobic gel1-Myristoyl-sn-glycero-3-phosphocholine8%Oleic acid5%Almond Oil3%Vaseline17%Cyclomethicone54%Dimethiconol13%

[0045] The gel is prepared by dispersing the 1-myristoyl-sn-glycero-3-phosphocholine, the oleic acid and the vaseline in a preformed mixture of cyclomethicone and dimethiconol.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Described is a product containing at least one lysophospholipid and at least one fatty acid, as a combined preparation for simultaneous, separate or sequential use, to be topically applied, in order to temporarily and reversibly inhibit a neuromuscular junction or the release of acetylcholine from autonomic nerve endings; this product can be used for treating hyperhidrosis conditions and for the cosmetic treatment of facial and other body wrinkles and, in general, human syndromes caused by the hyperactivity of peripheral nerve terminals.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application claims the benefit of priority from European Patent Application No. 05015645.4 filed on Jul. 19, 2005, the contents of which are incorporated herein by reference. FIELD OF APPLICATION [0002] The present invention refers, in general, to the pharmaceutical and cosmetic sector of industry. [0003] The invention concerns, in particular a product for topical application, which is capable of causing a localized and temporary inhibition of peripheral synaptic terminals leading to blockade of neurotransmitter release at different types of nerve endings, including the neuromuscular junction (NMJ) and autonomic nerve endings that control glandular tissue and smooth muscles. Such a product can thus be used for treating a variety of pathological conditions caused by the hyperfunctionality of peripheral nerve terminals including palmar and axillary hyperhidrosis, and the pharmaco-cosmetic treatment of facial and neck wrinkles causing...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K8/55
CPCA61K31/202A61K31/685A61K2300/00A61P21/00
Inventor CACCIN, PAOLADE GRANDIS, DOMENICOMONTECUCCO, CESARERAVENNI, ROBERTARIGONI, MICHELAROSSETTO, ORNELLASCHIAVO, GIAMPIETRO
Owner CESARE MONTECUCCO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap